Fetal cardiac screening: Why bother?

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 95, Issue 1, 2010, Pages

  Sharland, G ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL EXAMINATION; CONGENITAL HEART DISEASE; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FETUS DEATH; FETUS HEART; GREAT VESSELS TRANSPOSITION; HEART; HUMAN; NEWBORN SCREENING; OBSTETRIC CARE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRENATAL PERIOD; PRIORITY JOURNAL; PULSE OXIMETRY; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; SURVIVAL RATE; TRAINING;

EID: 74749093345     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900.
2. Abu-Harb M, Hey E, Wren C. Death in infancy from unrecognised congenital heart disease. Arch Dis Child 1994;71:3-7.
3. Richmond S, Wren C. Early diagnosis of congenital heart disease. Semin Neonatol 2001;6:27-35.
4. Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child - Fetal Neonat Edn 2008;93:F33-5.
5. Griebsch I, Knowles RL, Brown J, et al. Comparing the clinical and economic effects of clinical examination, pulse oximetry, and echocardiography in newborn screening for congenital heart defects: a probabilistic cost-effectiveness model and value of information analysis. Int J Technol Assess Health Care 2007;23:192-204.
6. Granelli A deW, Wennergren M, Sandberg K, et al. Impact of pulse oximetry screening on the detection on duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ 2009;338:145-9.
7. Allan LD, Sharland GK, Milburn A, et al. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol 1994;23:1452-8.
8. Allan L, Hornberger L, Sharland G. Textbook of fetal cardiology. London: Greenwich Medical Media Limited, 2000.
9. Hyett J, Perdu M, Sharland G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999;318:81-5.
10. Pandya PP, Snijders RJM, Johnson S, et al. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynaecol 1995;102:957-62.
11. Bonnet D, Coltri A, Butera G, et al. Fetal detection of transposition of the great arteries reduces morbidity and mortality in newborn infants. Circulation 1999;99:916-18.
12. Khoshnood B, De Vigan C, Vodovar V, et al. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983-2000: a population-based evaluation. Pediatrics 2005;115:95-101.
13. Tworetzky W, McElhinney DB, Reddy MV, et al. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001;103:1269-73.
14. Franklin O, Burch M, Manning N, et al. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 2002;87:67-9.
15. Chew C, Stone S, Donath SM, et al. Impact of antenatal screening on the presentation of infants with congenital heart disease to a cardiology unit. J Paediatr Child Health 2006;42:704-8.
16. Fisher J. Termination of pregnancy for fetal abnormality: the perspective of a parent support organisation. Reproduct Health Matters 2008;16(31 Suppl):57-65.
17. Williams IA, Shaw R, Kleinman CS, et al. Parental understanding of neonatal congenital heart disease. Pediatr Cardiol 2008;29:1059-65.
18. Wilson JM, Jungner G. Principles and practice of screening for disease. WHO Chronicle 1968;22:1-163.
19. Bricker L, Garcia J, Henderson J, et al. Health Technology Assessment NHS R&D HTA Programme: ultrasound screening in pregnancy: a systematic review of the clinical effectiveness,cost-effectiveness and women's views. Health Technol Assess 2000;4:1-193.
20. UK National Screening Committee. Antenatal Ultrasound Screening Ultrasound Survey of England: 2002. UK National Screening Committee, April 2005.
21. Ultrasound Screening - Supplement to ultrasound screening for fetal abnormalities. London: Royal College of Obstetrics and Gynaecology, July 2000.
22. National Institute for Health and Clinical Excellence. Antenatal care - routine care for the healthy pregnant woman. Clinical guideline, March 2008. London: NICE, 2008.
23. Allan LD, Crawford DC, Chita SK, et al. Prenatal screening for congenital heart disease. BMJ 1986;292:1717-19.
24. Sharland GK, Allan LD. Screening for congenital heart disease prenatally. Results of a 2 1/2 year study in the South East Thames Region. Br J Obstet Gynaecol 1992;9:220-5.
25. Tegnander E, Eik-Nes S. The examiner's ultrasound experience has significant impact on the detection rate of congenital heart defects at the second-trimester fetal examination. Ultrasound Obstet Gynecol 2006;28:8-14.
26. Pezard P, Bonnemains L, Boussion F, et al. Influence of ltrasonographers training on prental diagnosis of congenital heart disease: a 12 year population-based study. Prenat Diagn 2008;28:1016-22.
27. Bull C, on behalf of British Paediatric Cardiac Association. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. Lancet 1999;354:1242-7.
28. Khoo NS, Van Essen P, Richardson M, et al. Effectiveness of prenatal diagnosis of congenital heart defects in South Australia: a population analysis 1999-2003. Aust NZ J ObstetGynaecol 2008;48:559-63.
29. Acherman RJ, Evans WN, Luna CF, et al. Prenatal detection of congenital heart disease in southern Nevada: the need for universal fetal cardiac evaluation. J Ultrasound Med 2007;26:1715-19.
30. Wigton TR, Sabbagha RE, Tamura RK, et al. Sonographic diagnosis of congenital heart disease: comparison between the four-chamber view and multiple cardiac views. Obstet Gynecol 1993;82:219-24.
31. Kirk JS, Riggs TW, Comstock CH, et al. Prenatal screening for cardiac anomalies: the value of routine addition of the aortic root to the four chamber view. Obstet Gynecol 1994;84:427-31.
32. Gandhi A, Patni S. Improving diagnosis of neonatal cardiovascular malformations: a genuine prospect or wishful thinking? Arch Dis Child 2008;93:545-6.